Optimizing Company Valuation via Cost of Capital by Les Nemethy and Sergey Glekov
Our firm recently performed two valuations on a pharmaceutical company two years apart. The owners were surprised by the surprisingly large jump in value, far larger than performance improvement might have justified.
Part V on Asset Classes: Preferred stocks By Les Nemethy and Loïc Cayssol
When investing in equities, investors have two main choices: common stocks or preferred shares. Whereas the previous article in this series dealt with common shares, this article focuses on preferred shares.
Part IV on Asset Classes: Common stocks by Les Nemethy and Sergey Glekov
This is the fourth article in a series on asset classes, designed to demonstrate that even in today’s “low interest” environment, one can generate reasonable returns on a diversified portfolio.